Men with low testosterone will soon have greater access to hormone replacement therapy following new changes to product labeling from the Food and Drug Administration. The Department of Health and Human Services announced on Thursday that the drug regulating agency would be updating labeling information related to the cancer risks of testosterone replacement, as well […]
Men with low testosterone will soon have greater access to hormone replacement therapy following new changes to product labeling from the Food and Drug Administration. The Department of Health and Human Services announced on Thursday that the drug regulating agency would be updating labeling information related to the cancer risks of testosterone replacement, as well […]
<iframe src="https://statesidedaily.com/embed/cluster/9eeeb7271d638e44e2e90c0db86a56503b66fbdf" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="HHS removes warning labels on testosterone replacement therapy"></iframe>
